CANDO

CANDO (Controlling Abnormal Network Dynamics using Optogenetics) is a world-class, multi-site, cross-disciplinary project to develop a cortical implant for optogenetic neural control. The goal is to create a first-in-human trial in patients with focal epilepsy. This seven year, £10M Innovative Engineering for Health Award, funded by the Wellcome Trust and the Engineering and Physical Sciences Research Council (EPSRC) involves a team of over 30 neuroscientists, engineers and clinicians based at Newcastle University, Imperial College London, University College London and The Newcastle Hospitals NHS Foundation Trust... We are building a cutting edge, combined gene therapy and bioelectronic implant to prevent seizures in those with focal epilepsy.

Primary location: Newcastle Upon Tyne United Kingdom